Dataset Information

The 2022 report of synergetic roadmap on carbon neutrality and clean air for China: Accelerating transition in key sectors.

ABSTRACT: China is now confronting the intertwined challenges of air pollution and climate change. Given the high synergies between air pollution abatement and climate change mitigation, the Chinese government is actively promoting synergetic control of these two issues. The Synergetic Roadmap project was launched in 2021 to track and analyze the progress of synergetic control in China by developing and monitoring key indicators. The Synergetic Roadmap 2022 report is the first annual update, featuring 20 indicators across five aspects: synergetic governance system and practices, progress in structural transition, air pollution and associated weather-climate interactions, sources, sinks, and mitigation pathway of atmospheric composition, and health impacts and benefits of coordinated control. Compared to the comprehensive review presented in the 2021 report, the Synergetic Roadmap 2022 report places particular emphasis on progress in 2021 with highlights on actions in key sectors and the relevant milestones. These milestones include the proportion of non-fossil power generation capacity surpassing coal-fired capacity for the first time, a decline in the production of crude steel and cement after years of growth, and the surging penetration of electric vehicles. Additionally, in 2022, China issued the first national policy that synergizes abatements of pollution and carbon emissions, marking a new era for China's pollution-carbon co-control. These changes highlight China's efforts to reshape its energy, economic, and transportation structures to meet the demand for synergetic control and sustainable development. Consequently, the country has witnessed a slowdown in carbon emission growth, improved air quality, and increased health benefits in recent years.

SUBMITTER: Lei Y

PROVIDER: S-EPMC10641488 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

The 2022 report of synergetic roadmap on carbon neutrality and clean air for China: Accelerating transition in key sectors.

Lei Yu Y Yin Zhicong Z Lu Xi X Zhang Qiang Q Gong Jicheng J Cai Bofeng B Cai Cilan C Chai Qimin Q Chen Huopo H Chen Renjie R Chen Shi S Chen Wenhui W Cheng Jing J Chi Xiyuan X Dai Hancheng H Feng Xiangzhao X Geng Guannan G Hu Jianlin J Hu Shan S Huang Cunrui C Li Tiantian T Li Wei W Li Xiaomei X Liu Jun J Liu Xin X Liu Zhu Z Ma Jinghui J Qin Yue Y Tong Dan D Wang Xuhui X Wang Xuying X Wu Rui R Xiao Qingyang Q Xie Yang Y Xu Xiaolong X Xue Tao T Yu Haipeng H Zhang Da D Zhang Ning N Zhang Shaohui S Zhang Shaojun S Zhang Xian X Zhang Xin X Zhang Zengkai Z Zheng Bo B Zheng Yixuan Y Zhou Jian J Zhu Tong T Wang Jinnan J He Kebin K

Environmental science and ecotechnology 20231023

China is now confronting the intertwined challenges of air pollution and climate change. Given the high synergies between air pollution abatement and climate change mitigation, the Chinese government is actively promoting synergetic control of these two issues. The Synergetic Roadmap project was launched in 2021 to track and analyze the progress of synergetic control in China by developing and monitoring key indicators. The Synergetic Roadmap 2022 report is the first annual update, featuring 20 ...[more]

PMID: 37965046

Similar Datasets

Project description:BackgroundAtherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipoproteins in the vessel wall is central to any healthcare strategy to prevent ASCVD. Advances in current concepts about reducing cumulative exposure to apolipoprotein B (apo B) cholesterol-containing lipoproteins and the emergence of novel therapies provide new opportunities to better prevent ASCVD. The present update of the World Heart Federation Cholesterol Roadmap provides a conceptual framework for the development of national policies and health systems approaches, so that potential roadblocks to cholesterol management and thus ASCVD prevention can be overcome.MethodsThrough a review of published guidelines and research papers since 2017, and consultation with a committee composed of experts in clinical management of dyslipidaemias and health systems research in low-and-middle income countries (LMICs), this Roadmap identifies (1) key principles to effective ASCVD prevention (2) gaps in implementation of these interventions (knowledge-practice gaps); (3) health system roadblocks to treatment of elevated cholesterol in LMICs; and (4) potential strategies for overcoming these.ResultsReducing the future burden of ASCVD will require diverse approaches throughout the life-course. These include: a greater focus on primordial prevention; availability of affordable cholesterol testing; availability of universal cholesterol screening for inherited dyslipidaemias; risk stratification moving beyond 10-year risk to look at lifetime risk with adequate risk estimators; wider availability of affordable cholesterol-lowering therapies which should include statins as essential medications globally; use of adequate doses of potent statin regimens; and combination therapies with ezetimibe or other therapies in order to attain and maintain robust reductions in LDL-C in those at highest risk. Continuing efforts are needed on health literacy for both the public and healthcare providers, utilising multi-disciplinary teams in healthcare and applications that quantify both ASCVD risk and benefits of treatment as well as increased adherence to therapies.ConclusionsThe adverse effects of LDL-cholesterol and apo B containing lipoprotein exposure are cumulative and result in ASCVD. These are preventable by implementation of different strategies, aimed at efficiently tackling atherosclerosis at different stages throughout the human life-course. Preventive strategies should therefore be updated to implement health policy, lifestyle changes and when needed pharmacotherapies earlier with investment in, and a shift in focus towards, early preventive strategies that preserve cardiovascular health rather than treat the consequences of ASCVD.

Dataset Information

The 2022 report of synergetic roadmap on carbon neutrality and clean air for China: Accelerating transition in key sectors.

Publications

The 2022 report of synergetic roadmap on carbon neutrality and clean air for China: Accelerating transition in key sectors.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets